News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Pfizer Inc. Executive, Martin Mackay Jumps Ship to Head AstraZeneca PLC’s R&D
May 26, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- AstraZeneca Plc said on Wednesday it had appointed Martin Mackay from Pfizer Inc (PFE.N) as its global head of research and development, while Pfizer named Mikael Dolsten as its new R&D leader.
Twitter
LinkedIn
Facebook
Email
Print
People
AstraZeneca Pharmaceuticals LP
Pfizer
MORE ON THIS TOPIC
Earnings
Gilead Still Hungry for Deals as HIV Portfolio Grows, Veklury Crashes
October 31, 2025
·
2 min read
·
Tristan Manalac
IPO
Evommune Joins IPO Class With Planned $160M Raise for Immuno Pipeline
October 31, 2025
·
2 min read
·
Tristan Manalac
Earnings
Lilly Walks Pricing Tightrope With Upcoming Weight Loss Pill Orforglipron
October 30, 2025
·
4 min read
·
Annalee Armstrong
Earnings
Merck Vaccine Sales Drop as US Declines Strike Another Pharma
October 30, 2025
·
1 min read
·
Dan Samorodnitsky